Hypoxia of solid tumor compromises the therapeutic outcome of photodynamic therapy
(PDT) that relies on localized O2 molecules to produce highly cytotoxic singlet oxygen (1O2) …

Tumor hypoxia compromises the therapeutic efficiency of photodynamic therapy (PDT) as
the local oxygen concentration plays an important role in the generation of cytotoxic singlet …

An O2 self-evolving core–shell theranostic nanohybrid was developed by encapsulating a
nanoenzyme cerium oxide (CeOx) in a metal–organic framework (MOF). The hybrid reveals …

Metal–organic frameworks (MOFs) have been used for photodynamic therapy (PDT) of
cancers by integrating photosensitizers, which cause cytotoxic effects on cancer cells by …

Tumor hypoxia poses a significant challenge in photodynamic therapy (PDT), which uses
molecular oxygen to produce reactive oxygen species upon light excitation of a …

Tumor hypoxia severely limits the therapeutic effects of photodynamic therapy (PDT).
Although many methods for oxygen generation exist, substantial safety concerns …

Nanozymes as artificial enzymes that mimicked natural enzyme-like activities have received
great attention in cancer diagnosis and therapy. Biomimetic nanozymes require more …

Photodynamic therapy (PDT), as a light irradiation inducing reactive oxygen species (ROS)
generation for cancer treatment, offers facile and promising solutions with respect to …

Photodynamic therapy (PDT) is a well‐known method for cancer therapy in the clinic.
However, the inherent hypoxia microenvironment of solid tumors enormously restricts the …

Photodynamic therapy (PDT) is exploited as a promising strategy for cancer treatment.
However, the hypoxic solid tumor and the lack of tumor‐specific photosensitizer …